By activating the AMPK/Nrf2 signaling pathway, metformin amplifies endogenous antioxidant responses, providing neuroprotection in conditions such as cerebral ischemia and Alzheimer’s disease [133,134]. The gene discussed is NFE2L2; the disease is Alzheimer disease.